The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
Open accessAbstract
Among parasitic diseases, morbidity and mortality caused by leishmaniasis are surpassed only by malaria and lymphatic filariasis. However, estimation of the leishmaniasis disease burden is challenging, due to clinical and epidemiological diversity, marked geographic clustering, and lack of reliable data on incidence, duration, and impact of the various disease syndromes. Non-health effects such as impoverishment, disfigurement, and stigma add to the burden, and introduce further complexities. Leishmaniasis occurs globally, but has disproportionate impact in the Horn of Africa, South Asia and Brazil (for visceral leishmaniasis), and Latin America, Central Asia, and southwestern Asia (for cutaneous leishmaniasis). Disease characteristics and challenges for control are reviewed for each of these foci. We recommend review of reliable secondary data sources and collection of baseline active survey data to improve current disease burden estimates, plus the improvement or establishment of effective surveillance systems to monitor the impact of control efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Leishmaniasis: current situation and new perspectives
Desjeux, P. (2004) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,322
Reithinger, R., Dujardin, J.-C., Louzir, H., Pirmez, C., Alexander, B., & Brooker, S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70209-8 · Cited by 1,334
Effects of environmental change on emerging parasitic diseases
Patz, J. A., Graczyk, T. K., Geller, N., & Vittor, A. Y. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00141-7 · Cited by 1,206
The increase in risk factors for leishmaniasis worldwide
Desjeux, P. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90223-8 · Cited by 1,043
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Cañavate, C., Dedet, J.-P., Gradoni, L., Ter Horst, R., López-Vélez, R., & Moreno, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-07 · Cited by 937
Self-citationHotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E., Ehrlich Sachs, S., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 817
Alvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 812
Self-citationLeishmania and human immunodeficiency virus coinfection: the first 10 years
Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., López-Vélez, R., Molina, R., & Moreno, J. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.298 · Cited by 736
Self-citationSundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. K., & Murray, H. W. (2000) · Clinical Infectious Diseases · doi:10.1086/318121 · Cited by 664
Cited by
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team (2012) · PLoS ONE · doi:10.1371/journal.pone.0035671 · Cited by 5,141
“[4,52] We hope the data presented here will allow a more nuanced interpretation of published disease burden estimates, and the uncertainties in these data will spur activities to improve the evidence base for leishmaniasis and other neglected diseases.”
BackgroundInfluentialHotez, P. J., & Kamath, A. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000412 · Cited by 1,263
Feasey, N., Wansbrough-Jones, M., Mabey, D. C. W., & Solomon, A. W. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldp046 · Cited by 817
Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis
QUINNELL, R. J., & COURTENAY, O. (2009) · Parasitology · doi:10.1017/s0031182009991156 · Cited by 487
The socioeconomic burden of parasitic zoonoses: Global trends
Torgerson, P. R., & Macpherson, C. N. L. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2011.07.017 · Cited by 404
Simarro, P. P., Cecchi, G., Paone, M., Franco, J. R., Diarra, A., Ruiz, J. A., Fèvre, E. M., Courtin, F., Mattioli, R. C., & Jannin, J. G. (2010) · International Journal of Health Geographics · doi:10.1186/1476-072x-9-57 · Cited by 394
Control of Visceral Leishmaniasis in Latin America—A Systematic Review
Romero, G. A. S., & Boelaert, M. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000584 · Cited by 378
Liu, D., & Uzonna, J. E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00083 · Cited by 364
Leishmania infections: Molecular targets and diagnosis
Akhoundi, M., Downing, T., Votýpka, J., Kuhls, K., Lukeš, J., Cannet, A., Ravel, C., Marty, P., Delaunay, P., Kasbari, M., et al. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.11.012 · Cited by 363
Vector biology meets disease control: using basic research to fight vector-borne diseases
Shaw, W. R., & Catteruccia, F. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0214-7 · Cited by 329
Global distribution maps of the leishmaniases
Pigott, D. M., Bhatt, S., Golding, N., Duda, K. A., Battle, K. E., Brady, O. J., Messina, J. P., Balard, Y., Bastien, P., Pratlong, F., et al. (2014) · eLife · doi:10.7554/elife.02851 · Cited by 284
Leishmaniasis vaccine: Where are we today?
Kedzierski, L. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.62881 · Cited by 202
Metadata
- Authors
- Bern, C., Maguire, J. H., & Alvar, J.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-10-29
- Volume
- 2
- Issue
- 10
- Pages
- e313
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2092135249
- Cited by
- 368
- References
- 58
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.